Violetta Cotreau
Keine laufenden Positionen mehr
Profil
Violetta Cotreau worked as the Chief Accounting Officer & Senior Vice President at Akebia Therapeutics, Inc. from 2020 to 2022.
Prior to that, she was the Senior Vice President & Controller at AMAG Pharmaceuticals, Inc. from 2016 to 2020.
She completed her undergraduate degree at the University of Massachusetts Lowell.
Ehemalige bekannte Positionen von Violetta Cotreau
| Unternehmen | Position | Ende |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30.12.2022 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.11.2020 |
Ausbildung von Violetta Cotreau
| University of Massachusetts Lowell | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
